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Abstract
Background: The purpose of the study was to examine the association between leisure-time physical activity
(LTPA), cardiovascular biomarkers and atherosclerosis among asymptomatic men with stable LTPA level throughout
the 25-year prospective observation.
Methods: Out of 101 asymptomatic men prospectively observed for their lifestyle and cardiovascular risk factors,
the cohort of 62 individuals (mean age 59.9 years) maintained a stable LTPA level during the 25-year observation.
Regular check-ups with the assessment of traditional risk factors, detailed measurements of LTPA level and aerobic
capacity were performed since baseline. At the latest follow-up (2011/12) a set of cardiovascular biomarkers was
measured using enzyme-linked immunosorbent assay. Subclinical atherosclerosis was assessed by means of
coronary artery calcification score and intima-media thickness (IMT). Endothelial function was evaluated by
means of the reactive hyperemia index. The studied biomarkers and indices were analyzed in the three cohorts
representing stable low-tomoderate (<2050 kcal/week), high (2050-3840 kcal/week) and very high LTPA
(>3840 kcal/week).
Results: At baseline the three cohorts were comparable in terms of age and clinical characteristics. At follow-up,
the cohort with stable high LTPA (2050-3840 kcal/week) had significantly lower concentrations of hs-CRP
(2.20 ± 1.0 mg/L), oxidized-LDL (68.35 ± 67.7 ng/mL), leptin (4.71 ± 3.07 ng/mL) and irisin (0.47 ± 0.13 μmol/L), and
the most favorable indices of atherosclerosis and endothelial function as compared with other groups (p < 0.05).
Regular marathon runners had increased concentrations of hsCRP (3.12 ± 1.4 mg/L), oxidized-LDL (249.8 ± 129 ng/ml),
Interleukine-6 (3.74 ± 2.4 pg/ml). A positive correlation was observed between hsCRP and IMT (r = 0.301; p < 0.01), and
irisin and IMT (r = 0.223; p < 0.05).
Conclusions: The data suggest that stable high LTPA (2050-3840 kcal/week) is associated with the most favorable
profile of key cardiovascular biomarkers and indices of atherosclerosis. Lifetime very high LTPA is associated with
increased lowgrade inflammation and may, therefore, exert an atherogenic effect.
Background
Regular physical activity has been shown as an inde-
pendent factor in prevention of cardiovascular diseases
in various populations [1–5]. Current recommendations
for adults indicate that meeting the minimum dose of
physical activity provides substantial health benefits. It is
also suggested that higher physical activity level may
exert additional favorable effects [6]. There is no doubt
that promoting active lifestyle remains one of the public
health priorities. However, due to the growing popularity
of vigorous trainings and prolonged sport events, there
is also a need to investigate the health impact of ex-
haustive exercies.
In the Healthy Men Clinic of the Medical University
of Lodz (Poland) we have a unique opportunity to
follow-up the population of physically active men for
over 25 years. Our previous report revealed a non-linear
association between physical activity level and indices of
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subclinical atherosclerosis [7]. The most favorable results
were found in the cohort representing intermediate
physical activity level associated with energy expenditure
between 2050 and 3840 kcal/week. No additional bene-
fits were found in men regularly exceeding this dose of
physical activity, and even a trend of worsening of some
indices of atherosclerosis was observed. Precise mecha-
nisms of this potentially deleterious effect of regular very
high physical activity has not been documented.
It is well established that numerous potent cells and
factors are involved in the process of atherosclerosis.
These include C-reactive protein, cytokines, chemokines,
adhesion molecules, angiogenic and other factors modify-
ing oxidative stress and low-grade systemic inflammation
[8–11]. The influence of physical activity on cardiovas-
cular system may be associated with exercise-related
modification of the above biomarkers, although precise
mechanisms of this relationship remain unclear [11, 12].
Most studies in this filed adopted cross-sectional designs
or short-term observation periods for the assessment of
physical activity.
Therefore, the purpose of the present analysis, was to
examine the association between regular physical activity
level and biomarkers of cardiovascular risk in the cohort
of asymptomatic men with stable leisure-time physical
activity (LTPA) throughout the 25-year observation. The
measurements were performed in the context of recog-
nized indices of subclinical atherosclerosis, i.e. coronary
artery calcium (CAC), intima-media thickness (IMT)
and microvascular endothelial function.
Methods
Ethics, consent and permissions
All the subjects were provided with written information
about the purpose and methodology of the study. The
protocol of the project was approved by the Medical
University of Lodz Ethics Committee.
Subjects
Recruitment procedure and other methods were de-
scribed in our previous papers [7, 13]. Briefly, the sub-
jects of the study consisted of male volunteers who
attended the Healthy Men Clinic and the Department of
Preventive Medicine, Medical University of Lodz
(Poland) since 1985. The latest follow-up was performed
in 2011/12 and enrolled 101 men (mean age 59. 7 ±
9.0 yrs; mean observation period: 24.7 ± 4.1 yrs). The
subjects were considered to be eligible if before the
examination they were asymptomatic, free from chronic
diseases and treatment (including aspirin, statins and
anti-hypertensive agents) and any important disability or
dementia. The whole group was initially divided into
three cohorts according to the tertiles of exercise-related
energy expenditure at baseline, i.e. low-to-moderate
(<2050 kcal/week), high (2050-3840 kcal/week) and very
high leisure-time physical activity level (>3840 kcal/week).
For the purpose of this analysis, we excluded the sub-
jects who substantially changed their leisure-time phys-
ical activity (LTPA) level since the baseline examination
(n = 39). Therefore, the final cohort consisted of 62
asymptomatic middle-aged and older men (mean age
59.9 ± 8.6 yrs) with stable LTPA level during the 25-year
observation.
The subjects were white men, predominantly married,
white collar workers with university or secondary educa-
tional level whose occupational activity was low. Major-
ity of the study participants were non-smokers. While all
the participants met current recommendations of physical
activity for adults [6], a vast majority of men exceeded the
minimal recommended dose of physical activity. They
were involved in regular aerobic exercises (jogging, walk-
ing, cycling, tennis), including participation in marathon
races.
In the years 1985-2005 all the subjects participated
in a similar panel of procedures including a detailed
interviewer-administered questionnaire, anthropomet-
ric and biochemical measurements, resting electrocardio-
gram and the graded submaximal exercise test. The latest
follow-up (2011/12) included also an assessment of ath-
erosclerosis indices and novel biomarkers.
Assessment of traditional risk factors and physical activity
All the participants completed a medical history ques-
tionnaire which included information on their health
status, family history of cardiovascular diseases, smoking,
alcohol consumption and detailed information about oc-
cupational and leisure-time physical activity. The level of
LTPA during the previous year was estimated. Exercise-
related energy expenditure was assessed on the basis of
the number of hours earmarked for weekly recreational
sport activities (kcal/week) according to the tables of
Fox [14].
At baseline the participants were divided into three
groups according to tertiles of energy expenditure:
<2050 kcal/week, 2050-3840 kcal/week, and >3840 kcal/
week (low-to moderate, high and very high PA level, re-
spectively). Next, we analyzed LTPA level throughout
the whole observation. On the basis of the mean energy
expenditure estimated at two-thirds of all follow-up ex-
aminations we defined subgroups of stable (maintained),
increased and decreased LTPA level. For the purpose of
this analysis we excluded individuals who substantially
changed their LTPA level throughout the observation.
In order to assess aerobic fitness the graded submaxi-
mal exercise test was carried out on a Monark type 818E
(Stockholm, Sweden) bicycle ergometer with 30 W incre-
ments every 3 min to achieve at least 85 % of maximal age-
predicted HR (220-age). The resultant linear regression
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equation was used to calculate the aerobic capacity index,
i.e. physical working capacity at 85 % of the maximal heart
rate (PWC85%HRmax). This methodology has been proposed
as a useful measure of aerobic power for epidemiological
studies [15].
Fasting blood samples were drawn from the antecubi-
tal vein. Enzymatic methods were used to determine
serum total cholesterol, glucose, triglycerides, uric acid
concentrations (COBAS INTEGRA 400 Plus, Roche).
High-density lipoproteins were measured by the precipita-
tion method. Concentration of low-density lipoproteins
was estimated using the Friedewald formula. Anthropo-
metric data were collected by standard methods.
Assessment of novel biomarkers and indices of
atherosclerosis
Biomarkers
Plasma concentration of high-sensitivity C-reactive pro-
tein (hsCRP), homocysteine, interleukine-6, oxidized
low-density lipoproteins (oxidized-LDL), soluble intracel-
lular adhesion molecule-1 (sICAM-1), soluble vascular cell
adhesion molecule-1 (sVCAM-1), leptin, resistin, adipo-
nectin and irisin were measured using enzyme-linked
immunosorbent assay kit (Diaclone, France; Labor Diag-
nostika Nord, Germany; BioVendor, Czech Republic;
Immundiagnostik AG, Germany; Axis-Shield Diagnostics
Ltd., Scotland). Fasting serum was stored according to the
manufacturer’s recommendations. Coronary artery calcifi-
cation. CAC scores were evaluated using the 64-slice com-
puted tomography scanner (SOMATOM Sensation 64,
Siemens Medical Solutions, Germany) and with Syngo
CaScore automatic analysis software (Siemens Healthcare,
Germany). The total CAC score was reported in Agatston
units [16].
Intima-media thickness
Carotid IMT was measured using ultrasound scanning
using the Siemens Acuson (Mountainview, CA) S2000
ultrasound system. Carotid atherosclerosis was defined
as increased carotid IMT (>0.9 mm) [17].
Reactive hyperemia
Peripheral arterial tonometry signals were obtained
using the EndoPAT 2000 device (Itamar MedicalInc.,
Israel). Endothelial function was assessed via RH-PAT
index. RHI values <1.67 were considered abnormal [18].
Statistical analysis
Continuous variables are expressed as mean ± standard
deviation (SD) or median (if not standard distribution).
Wilcoxon signed-rank test was used to assess the differ-
ences between baseline and final characteristics of the
study cohorts. Categorical variables were compared by
chi-square test or chi-square test with Yate’s correction.
The Kruskall-Wallis test and Dunnett’s test were used in
order to assess distribution of biomarkers according to
the level of LTPA and to compare differences between
groups. Spearman’s correlation was used to evaluate the
association between biomarkers and other continuous
variables. Logarithmic transformation of skewed data did
not change the direction or strength of the analyzed calcu-
lations. A p value < 0.05 was considered statistically signi-
ficant. All analyses were performed with STATISTICA
Windows XP version 9.1.
Results
Table 1 presents baseline characteristics of the whole stud-
ied group in the project (n = 101). Long-term changes in
traditional cardiovascular risk factors of the cohorts with
stable low-to-moderate, high, and very high LTPA (n = 62)
are showed in Table 2. At baseline all the three cohorts
were comparable in terms of age and clinical characteris-
tics. At follow-up, most of the analyzed traditional risk
factors changed substantially in all the groups. The LTPA
level decreased during the observation, with the most
striking fall in the mean energy expenditure was noticed
among the participants with the highest LTPA (p < 0.01).
While most of the parameters worsened, high-density
lipoproteins concentration increased and TG decreased
during the observation, especially among the most active
men (p < 0.05). Diastolic blood pressure and low-density
lipoproteins remained fairly stable between baseline and
follow-up examination. At follow-up the group with very
high LTPA level had significantly lower low-density
Table 1 Baseline characteristics of all participants of the
prospective observation (n = 101)
Baseline
Age, years 35.3 ± 6.4
Waist circumference, cm 85.1 ± 6.9
Body mass index, kg/m2 24.3 ± 2.8
Body fat, % 16.1 ± 4.2
Systolic blood pressure, mmHg 120.3 ± 12.9
Diastolic blood pressure, mmHg 78.1 ± 6.6
Triglycerides, mmol/l 1.27 ± 0.44
High-density lipoproteins, mmol/l 1.30 ± 0.28
Fasting plasma glucose, mmol/l 4.52 ± 0.56
Current smokers, n 17
Alcohol consumption, units/week 4.71 ± 3.6
Leisure-time physical activity, hours/week
Low/moderate intensity (≤6 METs) 2.9 ± 2.98
High/very high intensity (>6 METs) 4.8 ± 1.9
Exercise-related energy expenditure, kcal/week 3101.3 ± 2871.8
Physical working capacity, W/kg 2.41 ± 0.56
Data presented as mean ± SD unless otherwise stated
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lipoproteins, triglycerides, glucose, and higher high-
density lipoproteins than the cohort with the low-to
moderate LTPA group (Table 2). There were no statisti-
cally significant differences in terms of prevalence of
smoking and alcohol consumption between the studied
cohorts at follow-up.
Table 3 shows the relationships between novel biochem-
ical markers and indicators of subclinical atherosclerosis
in the whole studied group (n = 62). Positive correlation
was observed between hsCRP and IMT (p < 0.01), and
irisin and IMT (p < 0.05). No significant correlations
were found between CAC and either of the analyzed
biomarkers. Aerobic capacity was inversely related to
plasma irisin (p < 0.05).
Regarding endothelial function, a significant negative
relationship was noted between RHI and Il-6 (p < 0.01),
s-ICAM and leptin (p < 0.05) (data not shown in the
tables).
Distribution of the mean values of biomarkers’ levels
according to the long-term LTPA patterns is showed in
Table 4. When comparing the cohorts with maintained
LTPA level, the lowest hs-CRP, ox-LDL, leptin and irisin
concentrations were found among men with stable high
LTPA (2050-3840 kcal/week). Borderline correlation
(p = 0.0503) occurred in the analysis of Interleukine-6
across the three groups. The highest prevalence of
negative CAC, no cases of increased IMT and decreased
RHI were observed in the group with maintained high
LTPA (2050-3840 kcal/week) (Table 4).
Additional analysis was performed among men who
completed at least one marathon run during preceding
5 years (n = 5). As compared with other highly active indi-
viduals, the most striking findings comprised the pre-
valence of advanced calcification (four cases of CAC ≥
100 AU) and higher plasma concentration of hs-CRP
(3.12 ± 1.4 mg/L), oxidized-LDL (249.8 ± 129 ng/ml),
Interleukine-6 (3.74 ± 2.4 pg/ml) (data not shown in the
tables).
Table 2 Changes in traditional cardiovascular risk factors among middle-aged men with stable physical activity level during a 25-year
observation (n = 62)
Stable physical activity level during the 25-year observation
Low/moderate (<2050 kcal/week) High (2050-3840 kcal/week) Very high (>3840 kcal/week)
n=26 n=21 n=15
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Age, years 37.5±7.5 61.3±9.0*** 35.3±6.6 58.8±8.8*** 35.8±8.1 58.8±8.1***
Current smokers, n 2 1 0 0 0 2
Body mass index, kg/m2 24.72±2.61 26.9±2.7 24.60±3.09 25.0±3.2 23.73±2.17 24.2±3.0
Systolic blood pressure, mmHg 119.8±8.9 132.2±14.7** 114.76±8.44 124.0±11.1** 118.93±12.59 125.4±14.9**
Diastolic blood pressure, mmHg 79.6±6.6 82.2±6.2 75.24±7.82 79.7±6.1 77.14±8.93 76.8±7.3
Total cholesterol, mmol/L 5.21±1.02 5.65±1.08* 4.83±0.45 5.48±0.85* 4.90±0.79 5.48±0.87*
LDL-C, mmol/L 3.30±1.04 3.61±1.06* 2.91±0.50 3.37±0.71 3.00±0.28 3.28±0.69a
Triglycerides, mmol/L 1.27±0.58 1.32±0.49 1.16±0.35 1.16±0.57 1.29±0.55 1.02±0.41a
HDL-C mmol/L 1.27±0.63 1.41±0.39 1.36±0.27 1.36±0.40 1.37±0.40 1.81±0.45*a
Glucose, mmol/L 4.07±1.07 5.25±1.08** 4.14±0.26 4.84±0.48* 4.11±0.61 4.73±0.33*a
Energy expenditure, kcal/week 1077.3±619.3 1029.3±225.3b 2919.3±651.3 2703.81±449.2c 7383.33±3761.44 4800.88±949.2**
PWC/kg, (W/kg) 2.14±0.5 1.58±0.4** 2.55±0.79 1.99±0.4* 3.18±0.4 2.59±0.5*
Data presented as mean ± SD unless otherwise stated; *p<0.05; **p<0.01; ***p<0.001 (baseline vs follow-up within the same LTPA category); ap<0.05 (low-to-moderate
vs very high LTPA group at follow-up); bp<0.001 (low-to-moderate vs very high LTPA group at follow-up) cp<0.01 (high vs very high LTPA group at follow-up)
Abbreviations: LDL-C low density lipoproteins, HDL-C high density lipoproteins, PWC physical working capacity
Table 3 Relationships between biomarkers and indices of
subclinical atherosclerosis among men with stable physical
















ICAM-1, ng/mL 0.180 0.012 0.021




Leptin, ng/mL -0.070 -0.122 -0.064




Irisin, μmol/L -0.032 0.223* -0.261*
* p < 0.05 ** p < 0.01; Abbreviations: hsCRP high sensitivity C-reactive protein,
ICAM-1 soluble intracellular adhesion molecule-1, sVCAM-1 soluble vascular cell
adhesion molecule-1
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Discussion
The current study provided a comprehensive assessment
of cardiovascular biomarkers in relation to lifetime stable
physical activity patterns in asymptomatic middle-aged
men. To our knowledge this is the first research investi-
gating the relationship between a wide range of novel
biomarkers and recognized measures of atherosclerosis
in the unique cohort of men with stable LTPA level
tracked prospectively for a period of about 25 years.
Of note, the mean exercise-related energy expenditure
fell in all three groups over time, the statistically signifi-
cant reduction in the highest LTPA level group. Probably,
the age-related physiological decline in the possibilities for
performing exhaustive exercises resulted in substantial re-
duction of EE in this cohort at follow-up.
The obtained results revealed that the most beneficial
profile of biomarkers were observed in the cohort repre-
senting stable high LTPA level (i.e. energy expenditure
of 2050-3840 kcal/week). Higher LTPA level was associ-
ated with less favorable biochemical status and did not
differ substantially from the results obtained in the low-
to-moderate LTPA group.
Interestingly, low-to moderate LTPA level occured
not be sufficient to maintain fairly stable profile of
traditional risk factors. This group of men developed
more cardiometabolic disorders which could contrib-
ute to worse profile of novel biomarkers and indices
of atherosclerosis. However, the most favorable CVD
profile was observed among participants with the
highest LTPA. Therefore we could expect that also
profile of novel biomarkers and indices of atheroscler-
osis would be substantially better as compared to
lower activity groups. It seems that regular PA level
was a crucial mechanism, independent of other ana-
lyzed CVD risk factors, in modifying subclinical
atherosclerosis.
It is postulated that cardioprotective effects of physical
activity may result from affecting key inflammatory
biomarkers. Acute bouts of exercise initially activates se-
cretion of large doses of cytokines inducing a transient,
mostly proinflammatory status. However, a regular train-
ing may result in a chronic anti-inflammatory response
[11, 12]. The results of studies investigating the rela-
tionship between systematic exercise and cardiovascular
biomarkers are, nevertheless, inconsistent. While most
studies demonstrated inverse linear relationship between
exercise and inflammatory biomarkers [2, 19–21], others
did not confirm such associations [22, 23]. In our physically
Table 4 Distribution of novel biochemical markers and indices of atherosclerosis among men with stable physical activity level
patterns during 25 year-observation
Stable physical activity level during the 25-year observation
Low-to-moderate (<2050 kcal/week) High (2050-3840 kcal/week) Very high (>3840 kcal/week)
n=26 n=21 n=15
Age, years 61.3 ± 9.0 58.8 ± 8.8 58.8± 8.1
hsCRP, mg/L 2.93 ± 1.1 2.20 ± 1.0* 2.82 ± 1.3
Homocysteine, μmol/L 13.55 ± 9.0 14.75 ± 4.8 14.6 ± 5.5
Oxidized-LDL, ng/mL 119.76 ± 252.3 68.35 ± 67.7* 119.48 ± 113.4
(median) (56.80) (13.9) (49.50)
ICAM-1, ng/mL 498.77 ± 139.2 460.00 ± 148.8 511.2 ± 102.1
VCAM-1, ng/mL 698.55 ± 328.3 743.05 ± 272.4 617.63 ± 260.3
Interleukine-6, pg/mL 2.58 ± 5.6 1.02 ± 0.9a 2.88 ± 2.8
Leptin, ng/mL 9.10 ± 8.1 4.71 ± 3.07* 7.79 ± 5.18
Resistin, ng/mL 4.57 ± 1.8 4.99 ± 2.48 4.50 ± 1.42
Adiponectin, μmol/L 8.13 ± 2.8 8.99 ± 2.6 7.73 ± 4.4
Irisin, μmol/L 0.54 ± 0.14 0.47 ± 0.13* 0.48 ± 0.22
Coronary artery calcium 286.1 ± 361.9 10.7 ± 28.9 106.1 ± 278.3
(median) (121.3) (1.7)*** (6.30)
0, n 1 10** 6
Intima-media thickeness, mm 0.751 ± 0.19 0.641 ± 0.26b 0.750 ± 0.60
>0.9, n 5 0 1
Reactive hyperemia index 1.69 ± 0.4 2.00 ± 0.4 2.13 ± 0.5
<1.67, n 12 0** 3
Data presented as mean ± SD unless otherwise stated; *p<0.05; ** p<0.01; ***p<0.001; ap=0.0503; bp=0.0502. Abbreviations as in Table 2
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active cohorts, we did not find linear relationships be-
tween LTPA level and analyzed biomarkers. However,
significantly lower concentrations of hsCRP, oxidized-
LDL, Interleukine-6 and leptin were found in the cohort
with the intermediate LTPA level (energy expenditure of
2050-3840 kcal/week).
This cohort also had significantly fewer cases of positive
CAC, increased IMT and endothelial dysfunction. There-
fore, it is possible that such a level of LTPA may protect
against atherosclerosis through beneficial modification of
biomarkers involved in inflammation and lipids oxidation.
Some prior studies indicated that excessive exercises
might induce deleterious effects on several inflammatory
markers, atherosclerosis indices and overall morbidity
[24–28]. It has been demonstrated that high-intensity
prolonged exercise may cause an acute pro-inflammatory
response and substantial increase in inflammatory
markers or endothelial progenitors [24–26]. There is an
increasing body of evidence that the atherogenic effect of
excessive exercise could be explained, at least in part, by
increased oxidative stress, low-grade systemic inflamma-
tion and endothelial dysfunction. The results obtained in
our study confirm, to some extent, the above findings
indicating increased low-grade inflammation in subjects
with lifetime very high LTPA level. Moreover, mark-
edly increased concentrations of hs-CRP, oxidized-LDL,
Interleukine-6 and positive CAC among regular marathon
runners are consistent with some previous reports dem-
onstrating that habitual high-intensity exercise does
not reduce the magnitude of subclinical atherosclerosis
[29, 30]. These findings raise concerns and require further
investigations in order to distinguish not only sufficient,
but also a safe threshold of physical activity level.
In the available literature there are inconsistencies
concerning the association between PA and biomarkers
of oxidative stress and inflammation. Some authors [31]
showed an inverse relationship between PA and blood
ox-LDL levels, while others failed to document any cor-
relations or significant results were limited to selected
populations [32, 33]. In our study we have not found an
inverse relationship between lifetime LTPA level and
oxidative stress. Regular low-to-moderate PA as well as
excessive (very high) PA occurred less beneficial than
high PA level. Similar patterns were observed for hs-
CRP, Il-6 and indices of subclinical atherosclerosis. It
seems that energy expenditure below 2000 kcal may not
be sufficient in prevention of atherosclerosis. The prob-
able explanation of these results might be the fact that
the cohort with the lowest LTPA level developed sub-
stantially more metabolic disorders than the high LTPA
group. It has been shown that metabolic disorders are
associated with excess of reactive oxygen species and
pro-inflammatory status [34]. Based on our results,
exercise-related EE below 2050 kcal/week is not enough
to maintain metabolically healthy profile through middle
adulthood. Consequently, this level of physical activity
may not prevent age-dependent deterioration in inflam-
matory and oxidative stress system It seems that many
fundamental details of mechanisms linking dose-response
exercise to altered oxidative stress and inflammation have
yet to be discovered.
It might have been expected that advanced coronary
calcium, carotid IMT and endothelial dysfunction would
be related to less favorable status of analyzed biomarkers.
Indeed, we found significant correlations between IMT,
hs-CRP and irisin as well as between RHI, Il-6, s-ICAM
and leptin. However, no evident relationships between
CAC and either of the analyzed biomarkers were noted.
There are several studies demonstrating the associ-
ation between inflammation and atherosclerosis [8–10].
The CRP level has been shown to independently predict
future cardiovascular events and seems to have the most
established position in prevention and management of
cardiovascular diseases. However, studies analyzing the
association between hs-CRP and subclinical atheroscler-
osis produced conflicting results [34–38]. In the present
study we observed a strong positive association between
hs-CRP and IMT which is in line with other studies in-
dicating the important role of hs-CRP in the develop-
ment of carotid atherosclerosis [35, 36].
Regarding the relationship between CAC and inflam-
matory markers, correlations found in several previous
studies were no longer significant after adjusting for adi-
posity [5, 36, 38–40]. In our study, the lack of significant
relationship between CAC and the analyzed biomarkers
may be partially associated with a very low proportion of
men with excessive weight. Blaha et al. (2011) showed
that obesity was strongly associated with CAC and IMT
independently of hsCRP, while in the absence of obesity,
hsCRP was not associated with IMT [36]. It seems that
CAC and hs-CRP are closely related with adiposity and
might provide independent information on cardiovascu-
lar risk.
Little is known about the relationship between LTPA,
subclinical atherosclerosis and biomarkers involved in
regulating energy balance, like leptin or irisin. Irisin, a
novel myokine, is thought to be able to regulate cardio-
metabolic parameters and potentially influence athero-
sclerogenesis [41]. Training-induced changes in serum
concentrations of irisin remain still undefined. First re-
ports showed that endurance exercise in healthy adults
may increase plasma irisin as compared to the baseline
state [42, 39]. A few further studies could not confirm any
relationship between circulating irisin and physical activity
level [43]. In our analysis, we found a strong inverse
relationship between serum irisin and aerobic cap-
acity. These findings are consistent with the latest re-
port of Kerstholt et al. (2015) who observed inverse
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associations between serum irisin and exercise capacity
[44]. However, due to conflicting results of the previous
studies, further investigations are needed to address this
issue.
In the available literature we found only one study
investigating relationship between irisin and subclinical
atherosclerosis as measured by CAC or IMT. Sesti et al.
(2014) reported a significant positive correlation between
circulating irisin and IMT and an inverse relationship be-
tween irisin and insulin sensitivity among 192 adults [45].
The authors suggest that increased release of irisin by adi-
pose/muscle tissue reflected a response to deterioration of
insulin sensitivity or a compensatory increase to overcome
an underlying irisin resistane. In our cohort, we also found
a significant positive relationship between irisin and ca-
rotid IMT, but the possible explanation of this finding
is difficult as the probability of insulin resistance among
normal weight physically active men is very low.
Regarding endothelial function, the results obtained in
the present study are consistent with the findings pre-
sented in our latest paper [13]. Both analyses demon-
strated the relationship between some inflammatory
markers and reactive hyperemia index. Consistently with
other reports, we confirm that sICAM-1 and Interleukine-
6 reflect impaired microvascular function, the initial per-
turbation in development of atherosclerosis [46–48].
A number of limitations of the present study should
be acknowledged. As data on LTPA was self-reported,
subjects might not have been accurate in estimating
their actual physical activity level. However, apart from a
questionnaire, an exercise test was also performed
during all follow-up visits. Physical working capacity
assessed during the test is thought to be a useful measure
of aerobic fitness which reflects the PA level.
Due to the cross-sectional assessment of novel bio-
markers and indices of atherosclerosis we could not fully
determine the direction of causality. Relatively small
sample size might limit statistical power for some ana-
lyses. Moreover, carotid IMT was not measured with an
automatic system which might result in some variability.
However, the measurements were performed with a vali-
dated tool and by an experienced operator. Among vari-
ous methods to measure endothelial function, we chose
the system assessing microvascular endothelial function.
The endoPAT system, although not the state-of-art
method, is a relatively simple, non-invasive, digital tool
of assessing microvascular function by measuring post-
occlusive reactive hyperemia. Another recognized non-
invasive method of measuring endothelial function is
brachial artery flow-mediated dilation. This method is,
however, technically challenging, relatively complex, and
the results may be difficult to compare between clinical
laboratories. Growing evidence show that both methods
provide distinct information and therefore may be
complementary in assessing endothelial function. Similar
methodology to assess atherosclerosis has been already
used in other studies [49, 50].
Despite the above limitations the study has important
advantages. Long-term observation of lifestyle and trad-
itional CVD risk, precise selection of the participants
and a comprehensive assessment of a range of clinical
parameters are among the most notable strengths of this
study. Comparable initial cardiovascular risk, age, ethni-
city, socioeconomic status, work-related PA of the studied
cohorts are of particular importance.
Conclusions
In summary, the results obtained in this analysis demon-
strate that regular intense exercises substantially exceeding
current recommendations may have an adverse impact on
cardiovascular system. It seems that lifetime very high
LTPA may exert an atherogenic effect by enhanced low-
grade inflammation and lipids oxidation. There is a need to
perform further prospective studies in larger samples of
highly active individuals in order to establish the sufficient
and safe threshold of physical activity in terms of athero-
sclerosis prevention.
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